OFA110635 was a study of IV ofatumumab in biologically naive RA patients who had failed MTX [16], while OFA110634 was a study of IV ofatumumab in biologically naive patients who had failed TNF antagonists [17]. Here, TNF is linked to rheumatoid arthritis.